Breaking news
What would happen if the EU forced Pfizer to stop delivering Covid vaccines? UK could miss out on 3.5m doses between now and February and rely totally on AstraZeneca’s plan to hit 2m per week by Monday Eurocrats proposed plans to stop vaccine exports could cut Britain’s supplies Pfizer – which manufactures doses in Belgium … Read more
A doctor has slammed the U.S. Food and Drug Administration (FDA) for not approving AstraZeneca-University of Oxford’s coronavirus vaccine. On Wednesday, Great Britain became the fist country in the world to grant authorization to the COVID-19 jab. The vaccine holds great appeal because it’s inexpensive – costing $3 to $4 per dose – and can … Read more
Drugs giant Astrazeneca reached a crucial milestone yesterday after regulators approved its Covid vaccine for use in the UK. The second-largest company on the FTSE 100 has spent months developing the jab with Oxford University. Around 530,000 doses will be available from next week, turbocharging the number of vaccines that can be rolled out in … Read more
It was a moment of maximum peril for Astrazeneca. The British drugs giant was laid low and attempting a turnaround, but the raiders were at the gate. Smelling an opportunity, American rival Pfizer swooped with a £69billion takeover bid which bosses hoped would cut costs and shrink its tax bills. But in the ensuing struggle, … Read more
Pfizer’s coronavirus vaccine could cost Britain £588million and wind up being seven times more expensive per dose than the one being developed by Oxford University. The jab, which the company this week claimed is 90 per cent effective and could be approved by regulators within weeks, is likely to cost at least £15 per dose … Read more
US regulators said on Wednesday that AstraZeneca can resume the US arm of its trial of Oxford University’s coronavirus vaccine, according to documents obtained by the Wall Street Journal. AstraZeneca paused global trials on September 8 due to what it called at the time an ‘unexplained illness’ in a British volunteer. Tests resumed on September … Read more
Dr João Pedro R. Feitosa (pictured), a 28-year-old from Rio De Janeiro, Brazil, was confirmed to be the volunteer who died in the Brazilian arm of AstraZeneca and the University of Oxford’s coronavirus vaccine trial A volunteer in the Brazilian arm of AstraZeneca and the University of Oxford’s coronavirus vaccine trial has died, the country’s health … Read more
A volunteer in the Brazilian arm of AstraZeneca and Oxford University’s coronavirus vaccine trial has died. Brazilian health authority Anvisa stated on Wednesday that it had just received information from an investigation into the death. The Federal University of São Paulo, which is helping coordinate phase III clinical trials in Brazil, separately said that the … Read more
Astrazeneca’s US Covid trial to resume after regulators fail to link patient’s illness with the vaccine By Daily Mail City & Finance Reporter Published: 22:12 BST, 20 October 2020 | Updated: 22:32 BST, 20 October 2020 Astrazeneca’s large, late-stage US trial has been on hold since September 6 Astrazeneca’s Covid-19 vaccine trial in the United … Read more
US widens probe into Astrazeneca’s Covid jab after patient develops rare spinal disorder during trials By Daily Mail City & Finance Reporter Published: 21:52 BST, 1 October 2020 | Updated: 22:05 BST, 1 October 2020 A probe into how a patient became ill during trials of Astrazeneca’s potential Covid-19 jab has been widened in the … Read more